First Human Study of HIV Vaccine Vacc-C5 to begin

Oslo 29.05.2012 – Animal Studies Indicate Similar Generation of Immune Responses as Those in HIV Patients who Naturally Suppress the Infection News Summary Open, clinical study, dose escalating, phase I/II, with Bionor Pharma`s second therapeutic HIV vaccine to begin at Oslo University Hospital. Researchers hope Vacc-C5 will prevent hyperactivation of immune system that leads to …

Read more

Successfully results from clinical study with Vacc-4x and Endocine

Oslo 10.05.2012 – Successful Immunization and Safety Documented in Nasal Administration Study of the HIV Vaccine Vacc-4x together with Endocine This New Option May Offer Easier Treatment Access for HIV Patients Globally News Summary * Vaccine related immune responses found in HIV patients given Vacc-4x together with Endocine through nasal administration in a placebo controlled …

Read more